Liver cirrhosis

EA Tsochatzis, J Bosch, AK Burroughs - The Lancet, 2014 - thelancet.com
Cirrhosis is an increasing cause of morbidity and mortality in more developed countries,
being the 14th most common cause of death worldwide but fourth in central Europe …

The clinical use of HVPG measurements in chronic liver disease

J Bosch, JG Abraldes, A Berzigotti… - Nature reviews …, 2009 - nature.com
Portal hypertension is a severe, almost unavoidable complication of chronic liver diseases
and is responsible for the main clinical consequences of cirrhosis. Measurement of the …

AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis

DE Kaplan, C Ripoll, M Thiele, BE Fortune… - Hepatology, 2024 - journals.lww.com
This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …

[PDF][PDF] Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of …

G Garcia‐Tsao, JG Abraldes, A Berzigotti… - Hepatology, 2017 - Wiley Online Library
This guidance provides a data-supported approach to risk stratification, diagnosis, and
management of patients with cirrhosis and portal hypertension (PH). A guidance document …

UK guidelines on the management of variceal haemorrhage in cirrhotic patients

D Tripathi, AJ Stanley, PC Hayes, D Patch, C Millson… - Gut, 2015 - gut.bmj.com
These updated guidelines on the management of variceal haemorrhage have been
commissioned by the Clinical Services and Standards Committee (CSSC) of the British …

Assessing portal hypertension in liver diseases

A Berzigotti, S Seijo, E Reverter… - Expert review of …, 2013 - Taylor & Francis
Portal hypertension is a common complication of chronic liver diseases and is responsible
for most clinical consequences of cirrhosis, which represent the more frequent causes of …

[HTML][HTML] Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical …

T Sauerbruch, M Mengel, M Dollinger, A Zipprich… - Gastroenterology, 2015 - Elsevier
Background & Aims Patients with cirrhosis and variceal hemorrhage have a high risk of
rebleeding. We performed a prospective randomized trial to compare the prevention of …

[PDF][PDF] Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension

C Villanueva, A Albillos, J Genesca, JG Abraldes… - …, 2016 - Wiley Online Library
Nonselective β‐blockers are useful to prevent bleeding in patients with cirrhosis and large
varices but not to prevent the development of varices in those with compensated cirrhosis …

[HTML][HTML] Non invasive evaluation of portal hypertension using transient elastography

L Castera, M Pinzani, J Bosch - Journal of hepatology, 2012 - Elsevier
The development of portal hypertension is a common consequence of chronic liver diseases
leading to the formation of esophageal and gastric varices responsible for variceal bleeding …

Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis

J Ferrusquía-Acosta, O Bassegoda, L Turco… - Journal of …, 2021 - Elsevier
Background & Aims Wedge hepatic vein pressure (WHVP) accurately estimates portal
pressure (PP) in alcohol-or viral hepatitis-related cirrhosis. Whether this also holds true in …